PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Spondylitis Program, Division of Rheumatology, Schroeder Arthritis Institute, University Health Network, Toronto, ON, Canada.\', \'Department of Pharmacology, Faculty of Medicine, Mazandaran University of Medical Sciences, Sari, Iran.\', \'Basic Sciences in Infectious Diseases Research Center, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran.\', \'Endocrinology and Metabolism Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.\', \'Department of Immunology, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran.\', \'Medical Sciences Research Center, Ghalib University, Kabul, Afghanistan.\', \'COVID-19 Directorate, Ministry of Public Health, Kabul, Afghanistan.\', \'Department of Medical Immunology and Allergy, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.\', \'Department of Medicine and Immunology, University of Toronto, Toronto, ON, Canada.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.3389/fimmu.2020.601886
?:hasPublicationType
?:journal
  • Frontiers in immunology
is ?:pmid of
?:pmid
?:pmid
  • 33488597
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 2.803
?:rankingScore_hIndex
  • 69
?:title
  • HLA, Immune Response, and Susceptibility to COVID-19.
?:type

Metadata

Anon_0  
expand all